Recurrent prostate cancer: Adding abiraterone-prednisone delays PSA progressionOctober 20, 2021Prostate Cancer
Prostate cancer: 68Ga-PSMA-11 PET scan may miss pelvic nodal metastasisOctober 20, 2021Prostate Cancer
Prostate cancer: 68Ga-PSMA-11 PET scan may miss pelvic nodal metastasisOctober 20, 2021Prostate Cancer
Lipiodol retention patterns show no impact on overall survival in HCCOctober 20, 2021Hepatocellular Carcinoma
TACE combination therapy improved outcomes in intermediate and advanced HCCOctober 20, 2021Hepatocellular Carcinoma
Nucleotide analog treatment shows promise in hepatitis B-related HCCOctober 20, 2021Hepatocellular Carcinoma
Repeat hepatic resection extends recurrence-free survival in recurrent HCCOctober 20, 2021Hepatocellular Carcinoma
Liver imaging algorithm predicts success of SBRT in hepatocellular carcinomaOctober 20, 2021Hepatocellular Carcinoma
Liver imaging algorithm predicts success of SBRT in hepatocellular carcinomaOctober 20, 2021Hepatocellular Carcinoma
Combination of chemotherapy and immunotherapy shows safety and efficacy for advanced HCCOctober 20, 2021Hepatocellular Carcinoma
Cabozantinib promotes survival in HCC for both ALBI subgroupsOctober 20, 2021Hepatocellular Carcinoma
Clinical staging predicts recurrence and survival in recurrent hepatocellular carcinomaOctober 20, 2021Hepatocellular Carcinoma
Machine learning risk calculator predicts HCC after liver transplantOctober 20, 2021Hepatocellular Carcinoma
Intense dosing needed for lenvatinib response in hepatocellular carcinomaOctober 20, 2021Hepatocellular Carcinoma
